Abbott Laboratories Corporation

Gowdahallin N Subba Rao

Dennis Y Lee

Mou-Ying Fu Lu

Compositions useful for the percutaneous administration of leuprolide comprise from about 1 to about 100 mg/ml of leuprolide in its free base form, a cutaneous membrane penetration enhancing component, and a pharmaceutically acceptable carrier. The cutaneous membrane transport enhancing component comprises from about 1 percent to about 15 percent urea, from 1 percent to about 5 percent menthol, from about 0.5 percent to about 5 percent methyl salicylate, and from about 0.5 percent to about 5 percent camphor, all percentages expressed in weight/volume based upon the total volume of the composition.

Growing community of inventors

Mundelein, IL, United States of America

Gowdahallin N Subba Rao